Activation of the Mitogen-Activated Protein Kinase Cascade Is Suppressed by Low Concentrations of Dexamethasone in Mast Cells

Journal of Immunology

Volumn 157, Issue 6, 1996, Pages 2374-2380

  Rider, Lisa G ^a,c   Hirasawa, Noriyasu ^b,d   Santini, Francesca ^b,e   Beaven, Michael A ^b,f  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^d TOHOKU UNIVERSITY   (Japan)

^e THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; ARACHIDONIC ACID DERIVATIVE; DEXAMETHASONE; IMMUNOGLOBULIN E RECEPTOR; IMMUNOSUPPRESSIVE AGENT; LYN PROTEIN-TYROSINE KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; ONCOPROTEIN; PHOSPHOLIPASE A; PROTEIN KINASE (CALCIUM,CALMODULIN); PROTEIN KINASE LYN; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; RAF PROTEIN; THAPSIGARGIN; TYROSINE;

ANIMAL; ARTICLE; CELL CULTURE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; IMMUNOLOGY; MAST CELL; MAST CELL LEUKEMIA; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; RAT;

ANIMALS; ANTIGENS; ARACHIDONIC ACIDS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENZYME ACTIVATION; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, BASOPHILIC, ACUTE; MAP KINASE KINASE 1; MAST CELLS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; PHOSPHOLIPASES A; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RAF; RATS; RECEPTORS, IGE; SRC-FAMILY KINASES; THAPSIGARGIN; TUMOR CELLS, CULTURED; TYROSINE;

EID: 0030587114     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Barnes, P. J., and I. Adcock. 1993. Anti-inflaramalory actions of steroids: molecular mechanisms. Trends Pharmacol. Sci. 14:436.
2. Boumpas, D. T., G. P. Chrousos, R. L. Wilder, T. R. Cupps, and J. E. Balow. 1993. Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Am. Intern. Med. 119:1198.
3. Berenstein, E. H., M. Garcia-Gil, and R. P. Siraganian. 1987. Dexamethasone inhibits receptor-activated phosphoinositide breakdown in rat basophilic leukemia (RBL-2H3) cells. J. Immunol. 138:1914.
4. Collado-Escobar, D., J. R. Cunha-Melo, and M. A. Beaven. 1990. Treatment with dexamethasone down-regulates IgE-receptor mediated signals and up-regulates adenosine-receptor mediated signals in a rat mast cell (RBL-2H3) line. J. Immunol. 144:244.
5. Collado-Escobar, D., H. Ali, and M. A. Beaven. 1990. On the mechanism of action of dexamethasone in a rat mast cell line (RBL-2H3 cells): evidence for altered coupling of receptors and G-proteins. J. Immunol. 144:3449.
6. 2+ ionophore A23187: induction of protein phosphatases. Adv. Prostaglandin Thromboxane Leukot. Res. 21A:265.
7. Heiman, A. S., and H. T. Crews. 1984. Hydrocortisone selectively inhibits IgE-dependent arachidonic acid release from rat peritoneal mast cells. Prostaglandins 27:335.
8. 2 in mast cells after cross-linking of Fcε-receptor. J. Immunol. 153:796.
9. Galli, S. J. 1993. New concepts about the mast cell. New Eng. J. Med. 328:257.
10. Robin, J. L., D. C. Seldin, K. F. Austen, and R. A. Lewis. 1985. Regulation of mediator release from mouse bone marrow-derived mast cells by glucocorticoids. J. Immunol. 135:2719.
11. Benhamou, M., E. Ninio, P. Salem, C. Hieblot, G. Bessou, C. Pitton, F.-T. Liu, and J. M. Mencia-Huerta, 1986. Decrease in IgE Fc receptor expression on mouse bone marrow-derived mast cells and inhibition of PAF-ether formation and of β-hexosaminidase release by dexamethasone. J. Immunol. 136:1385.
12. Daeron, M., A. R. Sterk, F. Hirata, and T. Ishizaka. 1982. Biochemical analysis of glucocorticoid-induced inhibition of IgE-mediated histamine release from mouse mast cells. J. Immunol. 129:1212.
13. Schleimer, R. P., D. W. MacGlashan, E. Gillespie, and L. M. Lichtenstein. 1982. Inhibition of basophil histamine release by anti-inflammatory steroids. II. Studies on the mechanism of action. J. Immunol. 129:1632.
14. Jouvin, M.-H. E., M. Adamczewski, R. Numerof, O. Letourneur, A. Valle, and J.-P. Kinet. 1994. Differential control of the tyrosine kinases lyn and syk by the two signaling chains of the high affinity immunoglobulin E receptor. J. Biol. Chem. 269:5918.
15. syk in high affinity IgE receptor signaling: identification as a component of pp72 and association with the receptor γ chain after receptor aggregation. J. Biol. Chem. 268:23318.
16. Margolis, B., P. Hu, S. Katzav, W. Li, J. M. Oliver, A. Ullrich, A. Weiss, and J. Schlessinger. 1992. Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs. Nature 356:71.
17. 2 complex, in RBL-2H3 rat basophilic leukemia cells. Mol. Cell. Biol. 12:3176.
18. lyn protein-tyrosine kinase. Proc. Natl. Acad. Sci. USA 91:11251.
19. Pribluda, V. S., C. Pribluda, and H. Metzger. 1994. Transphosphorylation as the mechanism by which the high-affinity receptor for IgE is phosphorylated upon aggregation. Proc. Natl. Acad. Sci. USA 91:11246.
20. Hirasawa, N., A. Scharenberg, H. Yamamura, M. A. Beaven, and J.-P. Kinet. 1995. A requirement for Syk in the activation of the MAP kinase/phospholipase A, pathway by FcεRI is not shared by a G protein-coupled receptor. J. Biol. Chem. 270:10960.
21. Scharenberg, A. M., S. Lin, B. Cuenod, H. Yamamura, and J.-P. Kinet. 1995. Reconstitution of interactions between tyrosine kinases and the high affinity IgE receptor which are controlled by receptor clustering. EMBO J. 14:3385.
22. Park, D. J., H. K. Min, and S. G. Rhee. 1991. IgE-induced tyrosine phosphorylation of phospholipase C-γ1 in rat basophilic leukemia cells. J. Biol. Chem. 266:24237.
23. 2 pathway in a rat mast cell line-Indications of different pathways for release of arachidonic acid and secretory granules. J. Immunol. 154:5391.
24. Stokoe, D., S. G. Macdonald, K. Cadwallader, M. Symons, and J. F. Hancock. 1994. Activation of Raf as u result of recruitment to the plasma membrane. Science 264:1463.
25. Leevers, S. J., H. F. Paterson, and C. J. Marshall. 1994. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature 369:411.
26. Avruch, J., X. F. Zhang, and J. M. Kyriakis. 1994. Raf meets Ras: completing the framework of a signal transduction pathway. Trends. Biochem. Sci. 19:279.
27. Marais, R., Y. Light, H. F. Paterson, and C. J. Marshall. 1995. Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation. EMBO J. 14:3136.
28. Santini, F., and M. A. Beaven. 1993. Tyrosine phosphylation of a Mitogen Activated Protein (MAP) kinase-like protein occurs at a late step in exocytosis: studies with tyrosine phosphatase inhibitors and various secretagogues in RBL-2H3 cells. J. Biol. Chem. 268:22716.
29. Offermanns, S., S. V. P. Jones, E. Bombien, and G. Schultz. 1994. Stimulation of mitogen-activated protein kinase activity by different secretory stimuli in rat basophilic leukemia cells. J. Immunol. 152:250.
30. Maeyama, K., R. J. Hohman, H. Metzger, and M. A. Beaven. 1986. Quantitative relationships between aggregation of IgE receptors, generation of intracellular signals, and histamine secretion in rat basophilic leukemia (2H3) cells: enhanced responses with heavy water. J. Biol. Chem. 261:2583.
31. Pribluda, V. S., and H. Metzger. 1992. Transmembrane signaling by the high-affinity IgE receptor on membrane preparations. Proc. Natl. Acad Sci. USA 89: 11446.
32. 2+ and purified isozymes in washed permeabilized cells. J. Biol. Chem. 268:1749.
33. Yamada, K., C. L. Jelsema, and M. A. Beaven. 1992. Certain inhibitors of protein serine/threonine kinases also inhibit tyrosine-phosphorylation of phospholipase Cγ1 and other proteins and reveal distinct roles for tyrosine kinase(s) and protein kinase C in stimulated, rat basophilic RBL-2H3 cells. J. Immunol. 149:1031.
34. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage t4. Nature 227:680.
35. Blank, U., C. Ra, L. Miller, K. White, H. Metzger, and J.-P. Kinet. 1989. Complete structure and expression in transfected cells of high affinity IgE receptor. Nature 317:187.
36. Benhamou, M., and R. P. Siraganian. 1992. Protein-tyrosine phosphorylation: an essential component of FcεRI signaling. Immunol. Today 13:195.
37. Eiseman, E., and J. B. Bolen. 1992. Engagement of the high-affinity IgE receptor activates src protein-related tyrosine kinases. Nature 355:78.
38. Boumpas, D. T. F. Paliogianni, E. D. Anastassiou, and J. E. Balow. 1991. Glucocorticosteroid action on the immune system: molecular and cellular aspects. Clin. Exp. Rheumatol. 9:413.
39. Claman, H. N. 1972. Corticosteroids and lymphoid cells. N. Engl. J. Med. 287: 388.
40. Paliogianni, F., S. S. Ahuja, J. P. Balow, J. E. Balow, and D. T. Boumpas. 1993. Novel mechanism for inhibition of human T cells by glucoconicoids: glucocorticoids inhibit signal transduction through IL-2 receptor. J. Immunol. 151:4081.
41. 2+ ionophores, antigen and diacylglycerol: essential role for protein kinase C and prevention by glucocorticosteroids. Biochim. Biophys. Acta 1091:385.
42. Reuther, G. W., H. Fu, L. D. Cripe, R. J. Collier, and A. M. Pendergast. 1994. Association of the protein kinases c-Bcr and Bcr-Abl with proteins of the 14-3-3 family. Science 266:129.
43. Scheinman, R. I., P. C. Cogswell, A. K. Lofquist, and A. S. Baldwin, Jr. 1995. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 270:283.
44. Auphan, N., J. A. DiDonato, C. Rosette, A. Helmberg, and M. Karin. 1995. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 270:286.
45. Ozawa, K., K. Yamada, M. G. Kazanietz, P. Blumberg, and M. A. Beaven. 1993. Different isozymes of protein kinase C mediate feed-back inhibition of phospholipase C and stimulatory signals for exocytosis in rat RBL-2H3 cells. J. Biol. Chem. 268:2280.
46. 2+-ionophore-induced secretion in a rat mast cell line cell. J. Pharm. Exptl. Therap. 276:837.
47. Blumer, K. J., and G. L. Johnson. 1994. Diversity in function and regulation of MAP kinase pathways. Trends Biochem. Sci. 19:236.
48. Pelech, S. L., and J. S. Sanghera. 1992. Mitogen-activated protein kinases: versatile transducers for cell signaling. Trends Biochem. Sci. 17:233.
49. Cowley, S., H. Paterson, P. Kemp, and C. J. Marshall. 1994. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NlH 3T3 cells. Cell 77:841.
50. Mansour, S. J., W. T. Matten, A. S. Hermann, J. M. Candia, S. Rong, K. Fukasawa, G. F. V. Woude, and N. G. Ahn. 1994. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265:966.
51. Reimann, T., D. Buscher, R. A. Hipskind, S. Krautwald, M. L. Lohmann-Matthes, and M. Baccarini. 1994. Lipopolysaccharide induces activation of the Raf-1/MAP kinase pathway: a putative role for RaM in the induction of the IL-1β and the TNF-α genes. J. Immunol. 153:5740.
52. Park, J. H., and L. Levitt. 1993. Overexpression of mitogen-activated protein kinase (ERK1) enhances T-cell cytokine gene expression: role of AP1, NF-AT, and NF-κB. Blood 82:2470.
53. Li, S., and J. M. Sedivy. 1993. Raf-1 protein kinase activates the NF-κB transcription factor by dissociating the cytoplasmic NFκB-IκB complex. Proc. Natl. Acad. Sci. USA 90:9247.
54. Kato, S., H. Endoh, Y. Masuhiro, T. Kitamoto, S. Uchiyama, H. Sasaki, S. Masushige, Y. Gotoh, E. Nishida, H. Kawashima, D. Metzger, and P. Chambon. 1995. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270:1491.